$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is it okay to take sunitinib for stromal tumors?
2026-02-01 22:25:32
Check Details
Instructions for sofosbuvir and velpatasvir (Epclusa)
2026-02-01 22:25:32
Check Details
What is sofosbuvir and velpatasvir (Epclusa)?
2026-02-01 22:25:32
Check Details
Is sofosbuvir and velpatasvir (Epclusa) on the market?
2026-02-01 22:25:32
Check Details
Why is sofosbuvir and velpatasvir (Epclusa) expensive in China? What is the domestic price?
2026-02-01 22:25:32
Check Details
How much does Sofosbuvir and Velpatasvir (Epclusa) cost?
2026-02-01 22:25:32
Check Details
Are there any side effects of sofosbuvir and velpatasvir (Epclusa)? Is it serious?
2026-02-01 22:25:32
Check Details
Dosage and dosage of sofosbuvir and velpatasvir (Epclusa)
2026-02-01 22:25:32
Check Details
Efficacy of sofosbuvir and velpatasvir (Epclusa)
2026-02-01 22:25:32
Check Details
How much is sofosbuvir and velpatasvir (Epclusa) reimbursed by medical insurance and what is the medical insurance price?
2026-02-01 22:25:32
Check Details
Should Sofosbuvir and Velpatasvir (Epclusa) tablets be taken after meals?
2026-02-01 22:25:32
Check Details
When will Cabotegravir be available in China?
2026-02-01 22:25:32
Check Details
1
2
...
50
51
52
53
54
55
56
...
10215
10216
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Garsorasib Clinical Updates and KRAS G12C Targeted Therapy Prospects
2
Risankizumab vs. Ustekinumab Clinical Guide
3
Tafasitamab and Lenalidomide Combination Therapy Guide
4
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
5
Resmetirom (Rezdiffra) Safety Guide: Hepatotoxicity, Gallbladder Risks & Statin Interactions Explained
6
Metyrapone Guide: Diagnostic Testing for Adrenal Insufficiency
7
Gilteritinib Professional Medication Guide & Dosage Management
8
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
9
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia
10
FDA Accelerates Approval of Zongertinib: Precision Medicine Advancement for HER2-Mutated NSCLC
11
Ixazomib & Pomalidomide in Multiple Myeloma: Mechanisms & Clinical Insights
12
Etrasimod (Velsipity™): A Selective S1P Modulator Transforming Ulcerative Colitis Treatment